Lagging Obamacare Sign-Up Is a Giant Pain for HMOs
The malaise of uncertainty is disconcerting to Aetna
On Oct. 24, I wrote Aetna, Humana, Other HMOs Slip on Web Site Glitches and since then two of the eight stocks declined by 9.8% and 12.0%. Only one performed well with a gain 9.5%. One of the stocks was downgraded to hold from buy according to www.ValuEngine.com.
The eight stocks in today's table are overvalued by 8.1% to 122.4%. All have gains over the last 12 months between 12.8% and 92.4%. Only one is below its 200-day simple moving average, which reflects the risk of reversion to the mean for the other seven stocks.
Reading the Table
OV/UN Valued: Stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine.
VE Rating: A "1-engine" rating is a strong sell, a "2-engine" rating is a sell, a "3-engine" rating is a hold, a "4-engine" rating is a buy and a "5-engine" rating is a strong buy.
Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage.
Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months.